Lupus Clinical Trials in Philadelphia

Showing 41-60 of 252 trials

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725

A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis

Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV

Kyverna Therapeutics6 participantsStarted Apr 2023

Palo Alto, California, United States • Denver, Colorado, United States • Worcester, Massachusetts, United States +3 more locations

TERMINATEDPhase 2< 1 mile

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

NCT05591222

A Phase 2, double-blind, randomized, placebo-controlled parallel-group study to evaluate the efficacy and safety of daxdilimab in participants with moderate-to-severe active primary Discoid Lupus Erythematosus (DLE) refractory to standard of care.

Discoid Lupus Erythematosus

Amgen72 participantsStarted Dec 2022

North Little Rock, Arkansas, United States • Beverly Hills, California, United States • Fremont, California, United States +65 more locations

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

Lupus Trials in Other Cities

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

DISE: Phenotyping Obstruction Patterns

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Acquired Dyslexia Modeling and Treatment

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Lupus Landmark Study: A Prospective Registry and Biorepository

Study of Anti-Malarials in Incomplete Lupus Erythematosus

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Other Conditions in Philadelphia